“Vaccine-related major cutaneous reaction size correlates with cellular-mediated immune responses after tularaemia immunisation.”, Clin Transl Immunology, vol. 10, no. 1, p. e1239, 2021.
, “Validation and human factor analysis study of an infant weight estimation device.”, BMC Pediatr, vol. 20, no. 1, p. 30, 2020.
, “Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical Trial.”, JAMA Oncol, vol. 7, no. 4, pp. 544-552, 2021.
, “Validation of a Genomic Classifier that Predicts Metastasis Following Radical Prostatectomy in an at Risk Patient Population”, J Urol, vol. 190, pp. 2047-2053, 2013.
, “Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population.”, J Urol, vol. 190, no. 6, pp. 2047-53, 2013.
, “Validation of the NIDA-modified ASSIST as a Screening Tool for Prenatal Drug Use in an Urban Setting in the United States.”, J Addict Med, 2020.
, “Validation of the TAPS-1: A Four-Item Screening Tool to Identify Unhealthy Substance Use in Primary Care.”, J Gen Intern Med, vol. 32, no. 9, pp. 990-996, 2017.
, , “Variables affecting estimated glomerular filtration rate after renal transplantation in children: a NAPRTCS data analysis.”, Pediatr Transplant, vol. 14, no. 2, pp. 288-94, 2010.
, “Variables Affecting Estimated Glomerular Filtration Rate after Renal Transplantation in Children: A NAPRTCS Data Analysis”, Pediatr Transplant, vol. 14, pp. 288-294, 2010.
, “Variation of Community Consultation and Public Disclosure for a Pediatric Multi-Centered "Exception from Informed Consent" Trial”, Clin Trials, vol. 12, pp. 67-76, 2015.
, “Variation of community consultation and public disclosure for a pediatric multi-centered "Exception from Informed Consent" trial.”, Clin Trials, vol. 12, no. 1, pp. 67-76, 2015.
, “Varicella in the first year after renal transplantation: A report of the North American Pediatric Renal Transplant Cooperative Study.”, Pediatr Transpl., vol. 1, pp. 37-42, 1997.
, “Varicella in the first year after renal transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).”, Pediatr Transplant, vol. 1, no. 1, pp. 37-42, 1997.
, , “Vinorelbine Tartrate [in the treatment of breast cancer],”, American Hospital Formulary Service Drug Information, pp. 802-04, 1996.
, “Viral Inhibition Assay: A CD8 T Cell Neutralization Assay for Use in Clinical Trials of Human Immunodeficiency Virus-1 Vaccine Candidates”, J Infect Dis, vol. 201, pp. 720-729, 2010.
, “Viral inhibition assay: a CD8 T cell neutralization assay for use in clinical trials of HIV-1 vaccine candidates.”, J Infect Dis, vol. 201, no. 5, pp. 720-9, 2010.
, “Viral kinetics in untreated versus treated acute HIV infection in prospective cohort studies in Thailand.”, J Int AIDS Soc, vol. 20, no. 1, p. 21652, 2017.
, “Visual acuity after cataract surgery in patients with age-related macular degeneration: age-related eye disease study 2 report number 5.”, Ophthalmology, vol. 121, no. 6, pp. 1229-36, 2014.
, “Visual Acuity After Cataract Surgery in Patients with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 5”, Ophthalmology, vol. 121, pp. 1229-1236, 2014.
, “Visual Acuity as an Outcome Measure in Clinical Trials of Retinal Diseases”, Ophthalmology, vol. 114, pp. 1804-1809, 2007.
, “Visual acuity as an outcome measure in clinical trials of retinal diseases.”, Ophthalmology, vol. 114, no. 10, pp. 1804-9, 2007.
, “Visual Acuity Outcomes after Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 19.”, Ophthalmol Retina, vol. 4, no. 1, pp. 3-12, 2020.
, “Visual acuity outcomes after cataract surgery in patients with age-related macular degeneration: age-related eye disease study report no. 27.”, Ophthalmology, vol. 116, no. 11, pp. 2093-100, 2009.
,